华绿生物
(300970)
| 流通市值：14.29亿 | | | 总市值：14.31亿 |
| 流通股本：1.18亿 | | | 总股本：1.18亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 336,898,188.19 | 409,952,778.49 | 487,060,903.57 | 550,110,702.21 |
| 应收票据及应收账款 | 19,968,064.1 | 18,685,725.04 | 16,642,628.82 | 15,564,058.05 |
| 应收账款 | 19,968,064.1 | 18,685,725.04 | 16,642,628.82 | 15,564,058.05 |
| 预付款项 | 4,550,065.87 | 6,147,736.21 | 10,745,962.79 | 7,150,310.56 |
| 其他应收款合计 | 3,698,956.67 | 3,521,697.69 | 4,381,191.48 | 3,206,428.14 |
| 其中:应收利息 | 1,243,709.16 | 1,552,387.22 | 1,599,583.34 | 1,200,396.45 |
| 存货 | 178,406,941.41 | 188,202,443.04 | 189,749,827.96 | 173,812,831.84 |
| 其他流动资产 | 956,264.11 | 1,340,768.94 | 1,952,566.48 | 1,033,715.09 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 544,478,480.35 | 627,851,149.41 | 710,533,081.1 | 750,878,045.89 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 536,524.97 | 503,876.27 | 481,878.79 | 305,994.97 |
| 固定资产 | 1,199,596,769.94 | 1,225,629,761.25 | 1,161,633,483.39 | 1,085,132,061.02 |
| 在建工程 | 127,614,321.85 | 93,557,615.49 | 119,353,458.9 | 147,856,591.87 |
| 使用权资产 | 85,735,341.17 | 90,788,414.64 | 5,904,371.07 | 6,029,039.88 |
| 无形资产 | 58,114,208.94 | 58,547,303.71 | 57,839,113.53 | 52,342,541.2 |
| 长期待摊费用 | 200,716.86 | 268,862.79 | 337,008.72 | 405,154.65 |
| 其他非流动资产 | 34,397,322.87 | 21,823,424.43 | 41,718,474.99 | 55,253,678.18 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,506,195,206.6 | 1,491,119,258.58 | 1,387,267,789.39 | 1,347,325,061.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,050,673,686.95 | 2,118,970,407.99 | 2,097,800,870.49 | 2,098,203,107.66 |
| 流动负债: | | | | |
| 短期借款 | - | - | 24,022,000.01 | 24,019,800.01 |
| 应付票据及应付账款 | 72,728,321.13 | 78,525,974.52 | 80,375,382.96 | 66,017,469.44 |
| 应付账款 | 72,728,321.13 | 78,525,974.52 | 80,375,382.96 | 66,017,469.44 |
| 预收款项 | 2,869,194.28 | 3,635,972.95 | - | - |
| 合同负债 | - | 3,635,972.95 | 3,074,942.37 | 3,667,247.73 |
| 应付职工薪酬 | 23,996,463.04 | 28,106,522.52 | 20,477,411.41 | 19,202,167.13 |
| 应交税费 | 209,230.4 | 257,873.01 | 281,018.39 | 1,139,702.43 |
| 其他应付款合计 | 50,948,230.17 | 59,420,139.72 | 53,680,109.73 | 32,511,600.38 |
| 一年内到期的非流动负债 | 42,086,824.89 | 63,826,661.9 | 91,598,568.93 | 93,292,002.37 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 192,838,263.91 | 233,773,144.62 | 273,509,433.8 | 239,849,989.49 |
| 非流动负债: | | | | |
| 长期借款 | 163,763,444.23 | 170,412,821.96 | 179,711,784.35 | 190,585,196.72 |
| 租赁负债 | - | 99,095,668.18 | - | 453,329.21 |
| 长期应付款 | 99,884,057.23 | 99,095,668.18 | 169,873.68 | - |
| 递延收益 | - | 47,749,115.2 | - | 44,959,260.09 |
| 其他非流动负债 | 45,583,492.09 | 47,749,115.2 | 42,931,560.15 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 309,230,993.55 | 317,257,605.34 | 222,813,218.18 | 235,997,786.02 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 502,069,257.46 | 551,030,749.96 | 496,322,651.98 | 475,847,775.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 117,888,600 | 117,888,600 | 116,700,000 | 116,700,000 |
| 资本公积 | 879,218,886.09 | 873,013,614.58 | 855,489,106.7 | 843,928,623.03 |
| 减:库存股 | 30,012,706.01 | - | - | - |
| 盈余公积 | 21,976,268.59 | 21,976,268.59 | 21,976,268.59 | 21,976,268.59 |
| 未分配利润 | 536,514,868.72 | 534,775,322.44 | 580,190,890.61 | 611,555,549.37 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,525,585,917.39 | 1,547,653,805.61 | 1,574,356,265.9 | 1,594,160,440.99 |
| 少数股东权益 | 23,018,512.1 | 20,285,852.42 | 27,121,952.61 | 28,194,891.16 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,548,604,429.49 | 1,567,939,658.03 | 1,601,478,218.51 | 1,622,355,332.15 |
| 负债和股东权益合计 | 2,050,673,686.95 | 2,118,970,407.99 | 2,097,800,870.49 | 2,098,203,107.66 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-27 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |